Journal Menu► ▼ Journal Menu
Journal Browser► ▼ Journal Browser
Special Issue "Hyaluronic Acid for Biomedical Applications"
A special issue of Pharmaceutics (ISSN 1999-4923).
Deadline for manuscript submissions: closed (31 July 2019).
Prof. Dr. Jae Hyung Park Website E-Mail
School of Chemical Engineering, Samsung Advanced Institute for Health Sciences and Technology, Sungkyunkwan University, Suwon 16419, Korea
Interests: hybrid nanoparticles as theranostic nanomedicine; polymeric conjugates for cancer immunotherapy; antibody conjugates for regulation of immune checkpoints; injectable hydrogels for tissue engineering; siRNA delivery systems; therapeutic exosomes
Dr. Seunglee Kwon E-Mail
School of Chemical Engineering, Sungkyunkwan University, Suwon 16419, Korea
Interests: polymeric nanomedicine, exosome, drug delivery system, therapeutic ultrasound
Hyaluronic acid (HA), a non-immunogenic polysaccharide, is found in most connective tissues throughout the body and clinically used for over three decades. The unique viscoelastic behavior and hydrodynamic property of this ubiquitous macromolecule contribute to its extensive use as a biomaterial. HA can be chemically modified using pendant reactive groups to make it more useful or to transform it into the appropriate physical forms such as hydrogels, fibers, meshes, sponges, and nanoparticulate fluids for target applications. The potential utility of HA-based materials is likely to be expanded in various translational research particularly due to their versatile processing capability, biocompatibility, and efficacy.
This special issue will cover the recent advances in HA-based materials rationally designed for biomedical applications including but not limited to drug delivery, tissue engineering, and cosmetic uses.
Prof. Dr. Jae Hyung Park
Dr. Seunglee Kwon
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- drug delivery system
- tissue engineering
- regenerative medicine